PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients

Journal of Investigative Dermatology

Volumn 126, Issue 3, 2006, Pages 542-544

  Oseroff, Allan ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANTIGEN; BIOLOGICAL RESPONSE MODIFIER; CANCER ANTIBODY; CHEMOKINE; CYTOKINE; CYTOTOXIC AGENT; HEAT SHOCK PROTEIN 70; HLA A2 ANTIGEN; INTERLEUKIN 12; OXYGEN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; SONIC HEDGEHOG PROTEIN;

APOPTOSIS; AUTOOXIDATION; BASAL CELL CARCINOMA; BLEACHING; CANCER PREVENTION; CELL KILLING; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INNATE IMMUNITY; LIGHT; LIGHT ABSORPTION; MACROPHAGE; MAST CELL; NECROSIS; NEUTROPHIL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; REVIEW; SENSITIZATION; SKIN CANCER; TARGET CELL; TARGET CELL DESTRUCTION;

EID: 32844467523     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700207     Document Type: Note

References (24)

1. Asea A, Rehli M, Kabingu E, Boch JA, Baré O, Auron PE et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70. Role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem 277:15028-34
2. Berg D, Otley CC (2002) Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 47:1-17
3. Brown VL, Atkins CL, Ghali L, Cerio R, Harwood CA, Proby CM (2005) Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 141:985-93
4. de Graaf YGL, Kennedy C, Wolterbeek R, Collen AFS, Willemze R, Bouwes Bavinck JN (2006) Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126:569-574
5. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M et al. (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905
6. Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U et al. (2004) A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 151:196-200
7. Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681-91
8. Gollnick SO, Vaughan L, Henderson BW (2002) Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 6:1604-8
9. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L et al. (2003) Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88:1772-9
10. Korbelik M, Krosl G, Krosl J, Dougherty GJ (1996) The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 56:5647-52
11. Korbelik M, Dougherty GJ (1999) Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 59:1941-6
12. Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 65:1018-26
13. Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy (2005) Cancer Immunol Immunother published online 8 October 2005:1-10 (10.1007.5000262-005-008-4)
14. Krosl G, Korbelik M, Dougherty GJ (1995) Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 71:549-55
15. Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E et al. (2004) Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res 10:4498-50
16. Liu W, Oseroff AR, Baumann H (2004) Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells. Cancer Res 64:6579-87
17. Liu Y, Viau G, Bissonnette R (2004) Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice. J Cutan Med Surg 8:131-9
18. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH (1998) Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 134:248-9
19. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H et al. (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146:552-67
20. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA et al. (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309:1871-4
21. Oseroff AR, Shieh S, Frawley NP, Cheney R, Blumenson LE, Pivnick EK et al. (2005) Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 141:60-7
22. Rittenhouse-Diakun K, Van Leengoed H, Morgan J, Hryhorenko E, Paszkiewicz G, Whitaker JE (1995) The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol 61:523-8
23. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC (1997) Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 66:493-6
24. Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA (2005) Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol 125:1020-5